Atlas Trials

Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection

Clinical trial NCT04317963 · COMPLETED

Trial details

NCT number
NCT04317963
Sponsor
University of Illinois at Chicago
Status
COMPLETED
Study type
OBSERVATIONAL
Clostridium Difficile InfectionClostridium Difficile Infection Recurrence
Start date
2020-02-12
Primary completion
2023-02-22
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.